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Abstract
Cancer cachexia (CC) is a multifactorial syndrome with an unknown etiology. The
primary symptom is the progressive reduction of the body weight. Recently, down-
regulation of adipogenic and lipogenic genes were demonstrated to be early aﬀected
during cachexia progression in adipose tissue (AT), resulting in AT remodeling.
Thus, this study aimed to evaluate in a co-culture system the inﬂuence of the
Lewis Lung Carcinoma (LLC) tumor cells (c/c-LLC) in an established pre-
adipocyte cell line 3T3-L1 adipogenic capacity. c/c-LLC in the presence of 3T3-
L1 caused a reduction in lipids accumulation, suggesting that secretory tumor
cells products may aﬀect adipogenesis. Interestingly, a very early (day 2) down-
regulation of proliferator-activated receptor gamma (PPARg) and CCAAT/
enhancer-binding protein alpha (C/EBPa), followed by late genes (day 4 and 8),
adiponectin, perilipin, and fatty acid-binding protein 4 (FABP4). Caspase-3
expression was increased on the last day of cell diﬀerentiation; it occurred in the
expression of pro-inﬂammatory cytokines interleukin-6 (IL-6) and tumor necrosis
factor alpha (TNF-a). Overall, our results suggest that LLC secretory products
impair adipocyte diﬀerentiation in a co-culture system and increased apoptosis.
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In summary, our study has shown the inhibition of the adipogenic process in the
3T3-L1 co-culture system with LLC cells.
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1. Introduction
Cancer cachexia (CC) is described as a complex, multifactorial syndrome with a diﬃ-
cult treatment that directly impacts in the patient’s quality of life (Fearon et al., 2012;
Tsoli and Robertson, 2013; Blum et al., 2014). The main symptoms include involun-
tary and progressive bodyweight loss, anorexia, disruption of energymetabolism, sys-
temic inﬂammation and deﬁciency in immune system function, which makes CC
responsible for the deaths of 22e40% of cancer patients (Argiles et al., 2003; Tsoli
et al., 2014; Seelaender et al., 2015; Batista et al., 2016). During the development of
CC,many organs are aﬀected, such as liver, brain, immune system, heart, skeletalmus-
cle and adipose tissue (AT) (Batista et al., 2012a; Porporato, 2016). The depletion of fat
mass occurs faster than the observed in skeletal muscle, which suggests that AT is
aﬀected early during the syndrome (Fouladiun et al., 2005; Das et al., 2011). A
conceivable explanation is the down-regulation of pro-adipogenic transcription fac-
tors, i.e., peroxisome proliferator-activated receptor gamma (PPARg) and CCAAT/
enhancer-binding protein alpha (C/EBPa), phenotypic proteins, i.e., perilipin, fatty
acid-binding protein 4 (FABP4), triglyceride lipase (ATGL) and hormone-sensitive
lipase (HSL) (Bing and Trayhurn, 2009) directly inﬂuenced by the production of in-
ﬂammatory cytokines due to immune cell inﬁltration (Henriques et al., 2017). Those
are two signiﬁcant events during the AT remodeling induced by cancer cachexia
(Batista et al., 2016; Franco et al., 2017). AT atrophy and its consequent remodeling
is worsened by the due to increased lipolysis and decreased lipogenesis in adipocytes
(Ryden et al., 2008; Batista et al., 2012a; Henriques et al., 2017). Impairment in the
balance between the preadipocytes that entering in adipogenesis process and mature
adipocytes that are undergoing apoptosis, a process known as cell turnover has been
recently demonstrated in AT from an animal model of cancer cachexia (Arner and
Spalding, 2010; Franco et al., 2017).
In addition, several studies have emphasized the relationship between weight loss,
with a high concentration of inﬂammatory cytokines present in serum and tissue
of animal models and CC patients, such as interleukin-6 (IL-6), tumor necrosis factor
alpha (TNF-a) (Tsoli and Robertson, 2013; Argiles et al., 2014; Camargo et al.,
2015). Both adipocytes and tumor cells can secrete pro-inﬂammatory cytokines,
which together establish several diﬀerent functions, such as cell cycle control,
apoptosis signals, and control of the hormones expression that regulate energy bal-
ance (Trayhurn and Wood, 2004; Camargo et al., 2015). Inﬂammatory signals from
tumors intersect with the normal cross-talk between adipose tissue and other organs,
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leading to impaired energy balance and catabolism of fat and muscle (Tsoli and
Robertson, 2013; Seelaender et al., 2015). In the same way, in the setting of cancer
cachexia, IL-6 and TNF-a are considered to be critical drivers of lipolysis and fat
depletion, with recent evidence of AT production of these cytokines. Such scenario
is followed by increased recruitment of inﬂammatory cells that could account for the
elevated circulating levels of IL-6 observed in CC patients (Batista et al., 2012b,
2013, 2016) and animal model (Bing et al., 2006; Tsoli and Robertson, 2013).
It has been previously reported that pro adipogenic transcription factors as PPARg
and C/EBPa, are downregulated in the initial stage of the CC syndrome in visceral
fat depots, even before the local AT and systemic inﬂammation installation (Batista
et al., 2012a). This downregulation suggests that other factors may be involved
in reducing expression of these genes, at least during the early stages of the disease.
However, this phenomenon was not studied at cellular levels using in vitro model.
In this study, we evaluated whether co-culture with Lewis Lung Carcinoma (LLC)
tumor cells per se may inﬂuence the adipogenesis process, in particular
addressing the production of inﬂammatory cytokines by both tumor and 3T3-L1 cells.
2. Materials and methods
2.1. Cell culture
Swiss preadipocytes 3T3-L1 cell line (ATCC CL173 - American Type Culture
Collection, Manassas, VA, USA), were plated at 1  104 in 24-well culture plates
and cultured in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM) high glucose with
L-glutamine (4 mM) (Gibco, Carlsbad, CA, USA, Cat. No. 11965084), supple-
mented with 10% bovine serum (Gibco, Cat. No. 16170) and 2% penicillin with
streptomycin (Gibco, Cat. No. 15140122) at pH 7.4. The cells were maintained at
37 C with 5% carbon dioxide (CO2) so as not to reach complete conﬂuence until
they were induced to diﬀerentiate (Ailhaud, 2001). Preadipocytes were brought to
complete conﬂuence (day -2) and after two days of conﬂuence (day 0), the culture
medium was replaced by diﬀerentiation inducer medium (DIM), consisting of
DMEM supplemented with 10% fetal bovine serum (FBS) (Gibco, Cat. No.
12657), 1 mM dexamethasone (Sigma-Aldrich, St. Louis, MO, USA, Cat. No.
D4902), 0.5 mM 3-isobutyl-1-methylxanthine (IBMX) (Sigma, Cat. No. 15879)
and 1.67 mM bovine insulin (Sigma, Cat. No. 16634). From the second day of dif-
ferentiation, the cells were maintained in culture medium containing only 0.83 mM
insulin and 10% FBS which was changed every 48 hours for eight days (Alonso-
Vale et al., 2009). The co-culture formed with LLC (LL/2 LLC1 - ATCC CRL-
1642) tumor cells (c/c-LLC) was introduced to the preadipocyte 3T3-L1 culture
on day-2 of diﬀerentiation. The LLC cells were plated at 1 104 on Transwell ﬁlters
(Corning Inc, Corning, NY, USA, Cat. No. 3415) with 2 mm pore, therefore, without
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direct contact between the LLC and the preadipocytes, only shared the same culture
medium. The co-cultures were maintained at 37 C with 5% CO2 (Ailhaud, 2001). A
photographic record was conducted on days 0, 2, 4 and 8 of diﬀerentiation. At the
last day of the diﬀerentiation, the protocol was adopted staining by Oil Red-O.
2.2. Oil Red-O staining
After diﬀerentiation protocol, lipid levels of newly diﬀerentiated adipocytes were
quantiﬁed using the Oil Red-O staining (Amresco, Solon, OH, USA, Cat. No.
0684). Cells were washed with phosphate-buﬀered saline (PBS), ﬁxed in 10%
formalin for 30 minutes at 37 C; the cells were washed with water and incubated
for 5 minutes with 60% isopropanol. Subsequently, the isopropanol was discarded
and the cells were incubated for 5 minutes with a solution of Oil-Red-O. The stained
cultures were washed several times with water to be removed from all dye residue;
stained cells were visualized by light microscopy with the photographic record, then
the triacylglycerol (TAG) colored in red was quantiﬁed at 490 nm in Synergy H1
(Biotek, Winooski, VT, EUA).
2.3. Gene expression analyses
Total RNA was extracted and puriﬁed from 3T3-L1 samples using the RNeasy Mini
Kit (Qiagen, Hilden, Germany Cat. No. 74104) following manufacturer’s recom-
mendations. RNA concentrations were determined by measuring the absorbance
of 260/280 nm. Total RNA was used at 1 mg reaction containing oligodT (500
mg/ml), 10 mM of each dNTP, 5X First-Strand Buﬀer, DTT, and 200 U reverse tran-
scriptase (SuperScript II, Invitrogen). Gene expression analyses were measured us-
ing SYBR green qPCR master mix (Fermentas Life Sciences, Waltham, MA, USA)
as described for Batista Jr et al (Batista et al., 2012a). Primer sets for mouse preadi-
pocyte factor 1 (Pref-1) (NM_001190705.1: sense: GGG AGA ACC ATT GAT
CAC G and antisense: ACA ATG GAA CTT GCG TGG AC), CCAAT enhancer
binding protein beta (C/EBPb) (NM_001287738.1: sense: GCG CCG CCT TAT
AAA CCT and antisense: GCC ACT TCC ATG GGT CTA AA), CCAAT enhancer
binding protein alpha (C/EBPa) (NM_001287514.1: sense: TCC CGG GTA GTC
AAA GTC AC and antisense: CCT TCA ACG ACG AGT TCC TG), peroxisome
proliferator-activated receptor gamma (PPARg) (NM_001308354.1: sense: CAC
CTC TTT GCT CTG CTC CT and antisense: AGA CAA CGG ACA AAT CAC
CA), fatty acid-binding protein 4 (FABP4) (NM_024406.2: sense: CTT GTG
GAA GTC ACG CCT TT and antisense: CTG GTG CAG GTG CAG AAG T), per-
ilipin (NM_001113471.1: sense: CGT GCT CAG AGA GGT TAC AGC and anti-
sense: CAC TGC GGA GAT GGT GTT C), adiponectin (NM_009605.4: sense:
TGT CTG TAC GAT TGT CAG TGG A and antisense: TAA CGT CAT CTT
CGG CAT GA). The results for mRNA concentrations are expressed as a ratio
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over ribosomal protein L19 (RPL-19), which was ampliﬁed as a housekeeping gene
using the following primers: RPL-19 (NM_001159483.1: sense: CTG ATC AAG
GAT GGG CTG AT and antisense: ACC CTT CCT CTT CCC TAT GC).
2.4. Western blot analyses
The protein samples were extracted and puriﬁed through the speaker system 500 Vi-
vaspin MWCO PES (GE Healthcare, Piscataway, NJ, USA, Cat. No. 28-9322-37).
Western blot analyses were performed as described (Batista et al., 2012a). Primary
antibodies against caspase-3 (at 1:1000 dilution) (Abcam, Milton, Cambridge, UK.
Cat. No, ab44976), hormone-sensitive lipase (HSL) (at 1:4000 dilution) (Abcam
Cat. No. ab45422) and adipose triglyceride lipase (ATGL) (at 1:2000 dilution)
(Cell Signaling, Beverly, MA, USA, Cat. No, 2138S). All primary antibody incuba-
tions were made overnight at 4 C and secondary anti-rabbit IgG conjugated to HRP
(at 1:3000 dilution) (Cell Signaling, Cat. No. 7074) for 1 hour at room temperature.
2.5. ELISA
Cytokines IL-6 (M6000B), TNF-a (MTA00B) and adiponectin (MRP300) levels in
the culture medium were detected by commercial cell culture kit by enzymatic-
colorimetric ELISA according to the manufacturer’s instructions (R&D Systems,
Minneapolis, MN, USA).
2.6. Statistical analyses
Data analysis was performed using GraphPad Prism software 6 (GraphPad, San
Diego, CA, USA). The mean and  standard error (SE) of the mean were calculated
for all variables used. We used ANOVA two-way followed by Tukey’s post-test for
comparison of more than 2 averaged over time; the signiﬁcance adopted was p <
0.05.
3. Results
3.1. LLC co-culture system reduces adipogenesis
3T3-L1 preadipocytes were grown to conﬂuence, exposed to c/c-LLC (day -2) and
two days later (day 0) both cells were exposed to DIM. Later, we analyzed tempo-
rally (days 0, 2, 4 and 8) the diﬀerentiation potential of preadipocyte 3T3-L1 cells by
inducing them in the appropriate media into adipocytes. DIM-induced the adipo-
genic process in 3T3-L1 as expected (Ailhaud, 2001; Alonso-Vale et al., 2009;
Vernochet et al., 2009) and cells showed a progressive morphological change in
the co-culture system (Fig. 1 A). Diﬀerentiated cells stained positive with Oil
Red-O stain at day 8 (Fig. 1 B); the concentration of dye present in TAG
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accumulation of adipocytes were evaluated. At the end of the adipogenic protocol
(day 8), there was a decreased of 36.2% (p ¼ 0.004) in lipid accumulation in c/c-
LLC cells when compared to controls (Fig. 1 C). Data showed that c/c-LLC were
suﬃcient to inhibit the cellular diﬀerentiation process.
3.2. LLC aﬀects the intermediary/late genes related to adipogenic
process
To evaluate the main genes that participate in the adipogenic process during the
development of cellular diﬀerentiation, we determined the mRNA expression on
days 0, 2, 4 and 8 of several genes related to adipocyte phenotype such as Pref-1
(a marker of non diﬀerentiated adipocyte), C/EBPb (adipogenic protein related to
early adipogenesis), PPARg and C/EBPa (responsible for diﬀerentiation and matu-
ration of adipocytes), and FABP4, perilipin, and adiponectin (mature adipocyte
phenotype markers). Our data show that the c/c-LLC had an inhibitory eﬀect on
the expression of key genes involved in cell diﬀerentiation, i.e., PPARg, C/EBPa,
perilipin and FABP4 (Fig. 2 CeF). Interestingly, there was a reduction in the expres-
sion of PPARg (76.1%, p¼ 0.02) on day 4 (Fig. 2 D) and C/EBPa on day 4 (86.6%,
p¼ 0.0003) and day 8 (90.9% p¼ 0.005) of the diﬀerentiation period in their respec-
tive controls (Fig. 2 C). Regarding the genes related to mature phenotype, perilipin
Fig. 1. Adipocyte diﬀerentiation in 3T3-L1 cells. (A) recording of the adipogenic period from day 0 to
day 8 of 3T3-L1 cells in co-culture with LLC cells (c/c-LLC). (B) The lipid accumulation in cells in c/c-
LLC on day 8 using Oil Red-O staining. (C) Quantiﬁcation of Oil Red-O staining by absorbance (490
nm) of the cells in c/c-LLC. The data shown are the mean  SE (n ¼ 4). *p < 0.05.
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expression showed downregulation of 98.4% on day 2 (p < 0.001), day 4, 96.5% (p
¼ 0.0004) and day 8, 98.8% (p ¼ 0.0001) (Fig. 2 F) and, FABP4 downregulated
81.6% (p ¼ 0.004) on day 4 and 91% (p ¼ 0.0068) on day 8 (Fig. 2 E), both
compared to their respective controls. These data suggest the products secreted by
c/c-LLC may aﬀect intermediary and late genes expression during adipogenesis.
The expression of C/EBPb, did not have statistical signiﬁcance between the c/c-
LLC and control groups. The expression of Pref-1, a known repressor of adipocyte
diﬀerentiation (O’Connell et al., 2011), also had no statistical signiﬁcance between
the groups c/c-LLC and controls. Furthermore, we have identiﬁed that adipocytes in
c/c-LLC presented a decreased protein expression of key ATGL (70%, p ¼ 0,006)
and HSL (100%, p < 0.0001) (Fig 3 AeB).
3.3. C/c-LLC induces apoptosis in 3T3-L1
At the end of the cell diﬀerentiation protocol, we evaluated the expression levels of
one the proteins participating in the cell death signaling pathway, caspase-3. On day
eight there was a trend toward to increase of 2.2-fold, (p¼ 0.05) in the cleaved form
of the protein (Fig. 3 C), suggesting that c/c-LLC not only inhibits adipogenesis but
also stimulates apoptosis, possible compromising AT turnover.
3.4. C/c-LLC increases the secretion of inﬂammatory factors
The next step was to analyze temporally pro-inﬂammatory secretion in the culture
medium during the adipogenic protocol with c/c-LLC. Thus, we assessed on days
0, 4 and 8, the main cytokines present in the CC syndrome, such as TNF-a and
Fig. 2. The gene expression of adipogenic factors in 3T3-L1 cells. The gene transcript levels of Pref-1
(A), C/ebpb (B), C/ebpa (C), Pparg (D), Fabp4 (E) and Perilipin (F) in cells c/c-LLC on days 0, 2, 4 and
8 were examined by RT-qPCR normalized to Rpl-19 levels. The data shown are the mean  SE (n ¼ 3).
*p < 0.05; **p < 0.001; ***p < 0.0001.
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IL-6. During the adipogenic process, the levels of TNF-a in culture medium showed
large increased from day 4 (4.7-fold, p¼ 0.0007) when compared to their respective
control (Fig. 4 B). However, there was no diﬀerence in the preadipocyte TNF-a gene
expression between control and c/c-LLC during diﬀerentiation period (Fig. 4 E). The
Fig. 3. The protein expression in 3T3-L1 cells.Western blot analyses of HSL (A), ATGL (B) and caspase-3
(C) in cells c/c-LLC on day eight normalized to Ponceau Red. The data shown are the mean  SE (n ¼ 4).
*p< 0.05; **p< 0.001; ***p< 0.0001. Full sized western blot images are shown in Supplementary Fig. 1.
Fig. 4. The factors secreted by cells 3T3-L1 and LLC. Culture medium protein analyses of IL-6 (A),
TNF-a (B) and ADIPONECTIN (C) were examined by ELISA and gene expression levels of Il-6
(D), Tnf-a (E) and Adiponectin (F) were examined by RT-qPCR normalized to Rpl-19 levels. All the
groups were examined on days 0, 4 and 8. The data shown are the mean  SE (n ¼ 3). N/D (non-detect
data), *p < 0.05; **p < 0.001; ***p < 0.0001.
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secretion of IL-6 showed an increase from day 8 (p < 0.0001) when compared to
respective control (Fig. 4 A). IL-6 gene expression in the preadipocytes from c/c-
LLC showed upregulation observed on the eighth day of diﬀerentiation (Fig. 4
D). Adiponectin was also evaluated in the culture medium, showing decreased secre-
tion in c/c-LLC on fourth and eighth day, 57.1% (p< 0.003) and 20.9% (p< 0.0001)
respectively (Fig. 4 C). Gene expression of the adiponectin showed downregulation
from day 8 (p ¼ 0.0003) when compared to controls (Fig. 4 F).
4. Discussion
The downregulation of adipogenic factors and possible impairment of adipogenesis
in response to the presence of CC has been recently reported (Bing et al., 2006;
Batista et al., 2013). In this regard, despite adipocyte atrophy, and AT remodeling
are well characterized in cachexia (Bing et al., 2006; Batista et al., 2016), there is
no consensus if such eﬀects induced by cachexia would be a result of secreted prod-
ucts directly by the tumor and tumor host relation. Thus, we have analyzed in vitro
adipogenesis in a co-culture system to mimic the eﬀects of CC on adipocytes. In the
present study, co-culture of LLC promoted a decreased volume of the lipid droplets
in 3T3-L1 cells, compromising its maturation process (adipogenesis) in vitro. This
result was followed by downregulation of adipogenic and lipolytic genes expression,
increased in apoptosis markers and proinﬂammatory cytokines secretion by both tu-
mor cells and adipocytes. In this sense, taken together, these data suggest that the
presence of the tumor cells were able to inhibit the adipocytes maturation with
was associated with the increased levels of inﬂammatory cytokines.
In a co-culture system, the adipogenesis induced in 3T3-L1 cells was categorically
inhibited. As far as we know, this was the ﬁrst study that showed this eﬀect directly
induced by LLC cells. Also, we evaluated Pref-1 gene expression to label the pre-
adipocytes not compromised with adipogenesis (O’Connell et al., 2011). In this
way, we demonstrated that both analyzed condition (with or without LLC) sus-
pended the expression of Pref-1 during the development of diﬀerentiation, indicating
that both conditions were committed to adipogenesis, with no eﬀect of LLC. C/
EBPb is a well-known trigger of early adipogenesis being rapidly expressed in
the ﬁrst 4 hours after induction and responsible for driving C/EBPa and PPARg
expression (Prusty et al., 2002; Farmer, 2005). In our co-culture system, C/EBPb
expression in diﬀerentiating adipocytes was not altered when compared to their
respective controls, indicating that the tumor cell did not inﬂuence the early phase
of diﬀerentiation. On the other hand, the data presented here diﬀer with those
observed in the animal model. Bing et al. (2006), showed a reduction of C/EBPb
expression in mice bearing a MAC16 tumor. According to the authors, the reduction
of CCAAT/enhancer-binding protein and PPARg family proteins impair the main-
tenance of the mature adipocyte phenotype, thereby aggravating the cachectic
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condition (Bing et al., 2006). The PPARg and C/EBPa factors are described as key
regulators of adipogenesis since they participate in the expression of the other pro-
teins responsible for the mature adipocyte phenotype (Cristancho and Lazar, 2011).
Temporally, C/EBPb is directly linked to the expression of C/EBPa, in which it par-
ticipates in the expression of PPARg remaining self-regulated until the end of diﬀer-
entiation (Cristancho and Lazar, 2011). In the present study, inhibition of PPARg
and C/EBPa was observed in the presence of LLC from the fourth day of diﬀeren-
tiation, which corroborates the down-regulation of these proteins observed in AT
from animal (in vivo) models of induced cachexia (Bing et al., 2006; Batista
et al., 2012a; Tsoli et al., 2014). In addition, we show that such impairment occurs
in intermediate-late events of diﬀerentiation, not at the early events.
Seeking for further information regarding on adipogenesis inhibition, we have
analyzed some mature adipocytes markers, such as; FABP4, perilipin, HSL, and
ATGL. All those markers showed reduced protein expression throughout the diﬀer-
entiation period, which demonstrate the inhibition of the adipocyte maturing process
by LLC. These data suggest that the reduction of fat droplets observed in adipocytes
is due to the non-maturation of the adipocyte, and not through the process of
increased lipolysis, which is considered to be one of the main factors responsible
for the reduction of AT (Ryden et al., 2008; Tsoli et al., 2016).
The maintenance of cellularity (or cell viability) was also addressed and c/c-LLC
induced increase in both total and cleavage of the caspase-3 protein, suggesting
increased apoptosis. Interestingly, in Walker-256 tumor-bearing rats, a reduction
of the Pref-1/Adiponectin ratio and an increase in the activation of caspase-3 were
demonstrating in retroperitoneal AT, suggesting an impairment of the cellular turn-
over induced by CC. However, further studies should be performed actually to check
for apoptosis pathway modulation in adipocytes during CC.
Studies that emphasize the inhibition of the adipogenic process by-products secreted
by tumor cells have demonstrated that such eﬀect may occur due to the release of
exosomes derived from tumor cells (Wang et al., 2017). As well as the secretion
of pro-inﬂammatory cytokines such as TNF-a, which is described by inhibiting
the adipogenic process by inhibiting PPARg expression (Meng et al., 2001; Ruan
et al., 2002). Furthermore, considering that cell diﬀerentiation and apoptosis process
could be controlled by proinﬂammatory cytokines (Coppack, 2001), the next step
was to evaluate the main proinﬂammatory cytokines described as responsible for
the depletion of AT during cancer cachexia, in particular, IL-6 and TNF-a
(Batista et al., 2013; Tsoli and Robertson, 2013). In cachexia induced tumor-
bearing mice (LLC cells), both cytokines are increased in plasma levels (data not
shown). Thus, to verify the possible origin of IL-6 and TNF-a secretion in the culture
medium (adipocyte or LLC), the gene expression and cytokines secretion (culture
medium) from adipocytes was evaluated during cellular diﬀerentiation. IL-6 gene
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expression was performed at diﬀerent set points, together with the quantiﬁcation of
its secretion. Both results indicated high levels of this cytokine from mature adipo-
cytes, corroborating the hypothesis that the adipose cell is an essential source of IL-
6. Interestingly, previous results from our group have demonstrated that subcutane-
ous adipose tissue is an important source of IL-6 in cancer patients with cachexia.
Moreover, this cytokine has a positive correlation with mass body reduction and tu-
mor staging (Batista et al., 2013).
Diﬀerently from the IL-6 response, although TNF-a secretion was increased in the
culture medium, TNF-a gene expression in adipocytes was not modiﬁed during adi-
pogenesis. Interestingly, the data suggest that TNF-a secretion is primarily per-
formed by LLC, not by adipose cells. It is known that LLC is a potent producer
of TNF-a (Kim et al., 2009) and other studies emphasize its inhibitory role in adipo-
cyte maturation through the negative regulation of PPARg and C/EBPa expression
(Warne, 2003; Cawthorn et al., 2007). According to Cawthorn et al. (2007), the anti-
adipogenic action of TNF-a occurs through the activation of tumor necrosis factor
receptor 1-mediated death domain where it increases the activity of TCF4-
dependent transcriptional and stabilization of beta-catenin, which in turn inhibits
the expression of PPARg and C/EBPa in 3T3-L1 cells (Cawthorn et al., 2007). In
cancer cachexia patients, these circulating levels of TNF-a are elevated, but not
correlated with clinical markers of cachexia (Batista et al., 2013). In this study,
we did not evaluate the involvement of pathways involved in the inhibition process,
nor even the participation of other inﬂammatory cytokines expressed by the tumor
cell or present in the cachexia.
5. Conclusion
In summary, our study has shown the inhibition of the adipogenic process in a 3T3-
L1 co-culture system with LLC cells, which occurred in parallel with the increase of
inﬂammatory cytokines (TNF-a and IL-6) present in the culture medium. The secre-
tion of IL-6 showed the contribution from adipocytes. TNF-a was predominantly
produced by tumor cells, suggesting the participation of both cell types in the secre-
tion of inﬂammatory cytokines into the culture medium. Finally, these results rein-
force the importance of a better understanding of the interaction between the host
and tumor for the study of cancer cachexia.
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